← Evidence map

ReviewEndocrine, metabolic & immune disorders drug targets2026

Do SGLT2 Inhibitors Protect the Kidneys? An Alternative Explanation.

Jacob IlanyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39791179